Jubilant Life Sciences, an integrated Pharmaceuticals and Life
Sciences Company has received Abbreviated New Drug Application (ANDA)
approval from the US Food and Drug Administration (USFDA) for
Spironolactone Tablets, 25 mg, 50 mg and 100 mg, the generic version of
Aldactone (of GD Searle), which is used as a diuretic to treat fluid
retention (edema) caused by congestive heart failure and cirrhosis of
the liver.For more information ✆ - 0731-6642300 or Visit https://www.epicresearch.co/
No comments:
Post a Comment